Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost

BACKGROUND: We report the first-in-human safety and immunogenicity evaluation of PENNVAX-G DNA/modified vaccinia Ankara–Chiang Mai double recombinant (MVA-CMDR) prime-boost human immuonodeficiency virus (HIV) vaccine, with intramuscular DNA delivery by either Biojector 2000 needle-free injection sys...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Infect Dis
Main Authors: Ake, Julie A, Schuetz, Alexandra, Pegu, Poonam, Wieczorek, Lindsay, Eller, Michael A, Kibuuka, Hannah, Sawe, Fredrick, Maboko, Leonard, Polonis, Victoria, Karasavva, Nicos, Weiner, David, Sekiziyivu, Arthur, Kosgei, Josphat, Missanga, Marco, Kroidl, Arne, Mann, Philipp, Ratto-Kim, Silvia, Anne Eller, Leigh, Earl, Patricia, Moss, Bernard, Dorsey-Spitz, Julie, Milazzo, Mark, Laissa Ouedraogo, G, Rizvi, Farrukh, Yan, Jian, Khan, Amir S, Peel, Sheila, Sardesai, Niranjan Y, Michael, Nelson L, Ngauy, Viseth, Marovich, Mary, Robb, Merlin L
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Major Articles and Brief Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853809/
https://ncbi.nlm.nih.gov/pubmed/28968759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix456
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker